Sheridan Legacy invests in Lone Star Distribution

Sheridan Legacy Group has invested in Lone Star Distribution via a growth equity recap. Financial terms weren’t announced. Dallas-based Lone Star is a specialty distributor of sports nutrition and fitness products, including protein powders, creatine, bars and muscle enhancers.


CHICAGO–(BUSINESS WIRE)–Sheridan Legacy Group, a Chicago-based lower middle-market private equity firm, announced today the addition of Lone Star Distribution (“Lone Star”) to its portfolio through a growth equity recapitalization.

Lone Star, headquartered in Dallas, TX, is a national specialty distributor of sports nutrition and fitness products, including protein powders, creatine, bars, muscle enhancers, workout supplements, sleep aids and immune boosters, vitamins, weight loss supplements, and energy boosters. Lone Star operates six distribution centers located in Dallas, TX, Atlanta, GA, Indianapolis, IN, Shelton, CT, Pompano Beach, FL, and Las Vegas, NV.
“Lone Star has an exceptional track record of growth due to the Company’s dedication to cultivating strong relationships with customers and vendors. Its ability to expertly navigate a complex and dynamic industry sector has turned the Company into a market leader,” said Jonathan Lewis, Partner of Sheridan Legacy Group. “We are excited to partner with Gary Giles, Lone Star founder John Hoffmann, and the entire management team to support the company’s ongoing success and accelerate its expansion initiatives across the U.S.”
Gary Giles, the new CEO of Lone Star, said, “Sheridan Legacy Group represents a great strategic partner for us. Their innate understanding of the distribution and consumer markets, operational focus, and strategic guidance will help us leverage and expand existing operations while maintaining the Company’s focus on strong customer and vendor relationships.”
The transaction was led by Lewis, Sean Dempsey, and Chase Culbertson. Terms of the deal were not disclosed.
About Sheridan Legacy Group
Sheridan Legacy Group focuses on making private equity investments in support of leveraged buyouts, recapitalizations, and large minority financings of lower middle market growth companies across the healthcare and consumer sectors. For additional information or inquiries, please contact Jonathan Lewis, Partner, at 312-324-0879 or